These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37809107)

  • 1. Pulmonary exacerbations in early cystic fibrosis lung disease are marked by strong modulation of CD3 and PD-1 on luminal T cells.
    Giacalone VD; Giraldo DM; Silva GL; Hosten J; Peng L; Guglani L; Tirouvanziam R
    Front Immunol; 2023; 14():1194253. PubMed ID: 37809107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease.
    Margaroli C; Horati H; Garratt LW; Giacalone VD; Schofield C; Dittrich AS; Rosenow T; Dobosh BS; Lim HS; Frey DL; Veltman M; Silva GL; Brown MR; Schultz C; Tiddens HAWM; Ranganathan S; Chandler JD; Qiu P; Peng L; Scholte BJ; Mall MA; Kicic A; Guglani L; Stick SM; Janssens HM; Tirouvanziam R
    J Cyst Fibros; 2022 Nov; 21(6):967-976. PubMed ID: 35732550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway macrophages display decreased expression of receptors mediating and regulating scavenging in early cystic fibrosis lung disease.
    Slimmen LJM; Giacalone VD; Schofield C; Horati H; Manaï BHAN; Estevão SC; Garratt LW; Peng L; Tirouvanziam R; Janssens HM; Unger WWJ
    Front Immunol; 2023; 14():1202009. PubMed ID: 37457715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of inflammatory biomarkers in matched induced sputum and bronchoalveolar lavage of 2-year-olds with cystic fibrosis.
    Giacalone VD; Moncada-Giraldo D; Margaroli C; Brown MR; Silva GL; Chandler JD; Peng L; Tirouvanziam R; Guglani L;
    Pediatr Pulmonol; 2022 Sep; 57(9):2189-2198. PubMed ID: 35637404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis.
    Regamey N; Tsartsali L; Hilliard TN; Fuchs O; Tan HL; Zhu J; Qiu YS; Alton EW; Jeffery PK; Bush A; Davies JC
    Thorax; 2012 Feb; 67(2):164-70. PubMed ID: 22008188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAL Inflammatory Markers Can Predict Pulmonary Exacerbations in Children With Cystic Fibrosis.
    Ishak A; Stick SM; Turkovic L; Ranganathan SC; King L; Harrison J; Sly PD; Caudri D; Schultz A;
    Chest; 2020 Dec; 158(6):2314-2322. PubMed ID: 32622821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.
    Armstrong DS; Hook SM; Jamsen KM; Nixon GM; Carzino R; Carlin JB; Robertson CF; Grimwood K
    Pediatr Pulmonol; 2005 Dec; 40(6):500-10. PubMed ID: 16208679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease.
    Fantino E; Gangell CL; Hartl D; Sly PD;
    BMC Pulm Med; 2014 Feb; 14():28. PubMed ID: 24576297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1.
    Ingersoll SA; Laval J; Forrest OA; Preininger M; Brown MR; Arafat D; Gibson G; Tangpricha V; Tirouvanziam R
    J Immunol; 2015 Jun; 194(11):5520-8. PubMed ID: 25926674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group.
    Ratjen F; Rietschel E; Griese M; Ballmann M; Kleinau I; Döring G; Reinhardt D; Paul K
    Eur Respir J; 2000 Jan; 15(1):141-5. PubMed ID: 10678636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.
    Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N
    Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations.
    Martin C; Dhôte T; Ladjemi MZ; Andrieu M; Many S; Karunanithy V; Pène F; Da Silva J; Burgel PR; Witko-Sarsat V
    Front Immunol; 2022; 13():1012310. PubMed ID: 36248793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha.
    Ratjen F; Paul K; van Koningsbruggen S; Breitenstein S; Rietschel E; Nikolaizik W
    Pediatr Pulmonol; 2005 Jan; 39(1):1-4. PubMed ID: 15532079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.
    Turnbull AR; Pyle CJ; Patel DF; Jackson PL; Hilliard TN; Regamey N; Tan HL; Brown S; Thursfield R; Short C; Mc Fie M; Alton EWFW; Gaggar A; Blalock JE; Lloyd CM; Bush A; Davies JC; Snelgrove RJ
    J Cyst Fibros; 2020 Jan; 19(1):40-48. PubMed ID: 31176670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage.
    Erdmann N; Schilling T; Hentschel J; Lehmann T; von Bismarck P; Ankermann T; Duckstein F; Baier M; Zagoya C; Mainz JG
    Front Immunol; 2022; 13():947359. PubMed ID: 36466839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis.
    Seidl E; Kiermeier H; Liebisch G; Ballmann M; Hesse S; Paul-Buck K; Ratjen F; Rietschel E; Griese M
    J Cyst Fibros; 2019 Nov; 18(6):790-795. PubMed ID: 31029606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
    Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal wash as an alternative to bronchoalveolar lavage in detecting early pulmonary inflammation in children with cystic fibrosis.
    Pitrez PM; Brennan S; Turner S; Sly PD
    Respirology; 2005 Mar; 10(2):177-82. PubMed ID: 15823182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients.
    Wojewodka G; De Sanctis JB; Bernier J; Bérubé J; Ahlgren HG; Gruber J; Landry J; Lands LC; Nguyen D; Rousseau S; Benedetti A; Matouk E; Radzioch D
    PLoS One; 2014; 9(2):e88567. PubMed ID: 24533110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.